Objective: To evaluate the effects on the nutritional and metabolic parameters of a very-low-protein diet supplemented with ketoacids (VLPD þ KA) in comparison with a conventional low-protein diet (LPD) in chronic kidney disease (CKD) patients. Design: Prospective, randomized, controlled clinical study. Setting: Outpatient Clinic of the Nephrology Division of Federal University of São Paulo, Brazil. Subjects: The study involved 24 patients with advanced CKD (creatinine clearance o25 ml/min) that were randomly assigned to either a VLPD þ KA (VLPD þ KA group, 12 patients) or to a conventional LPD with 0.6 g/kg/day (LPD group, 12 patients). The patients were followed for 4 months. Results: Nutritional status was adequately maintained with both diets for the studied period. Protein intake and serum urea nitrogen decreased significantly only in the VLPD þ KA group (from 0.6870.17 to 0.4370.12 g/kg/day, Po0.05; from 61.4712.8 to 43.6714.9 mg/dl, Po0.001; respectively). Ionized calcium did not change in the VLPD þ KA group but tended to decrease in the LPD group. Serum phosphorus tended to decrease in the VLPD þ KA group probably as a result of a significant reduction in dietary phosphorus (5297109 to 3737125 mg/day, Po0.05) associated to the phosphorus-binding effect of the ketoacids. No change in these parameters was found in the LPD group. Serum parathormone increased significantly only in the LPD group (from 2417138 to 4947390 pg/ml, Po0.01). The change in PTH concentration was negatively correlated with changes in ionized calcium concentration (r ¼ À0.75, P ¼ 0.02) and positively correlated with changes in serum phosphorus (r ¼ 0.71, P ¼ 0.03) only in the LPD group. Conclusion: This study indicates that a VLPD þ KA can maintain the nutritional status of the patients similarly to a conventional LPD. Besides, an improvement in calcium and phosphorus metabolism and a reduction in serum urea nitrogen were attained only with the VLPD þ KA. Thus, VLPD þ KA can constitute another efficient therapeutic alternative in the treatment of CKD patients. Sponsorship: This study was supported by CAPES, Oswaldo Ramos Foundation and Fresenius Kabi, Ltda.
Introduction
Dietary intervention is one of the major components of chronic kidney disease (CKD) patients therapy and aims to minimize uremic symptoms and to provide optimum nutritional status. In order to limit the accumulation of nitrogenous waste products, and in the hope of slowing the progression of renal failure, dietary protein restriction has been recommended for patients with moderate to severe CKD (Mitch, 2002) .
Various dietary regimens have been proposed: a conventional low-protein diet (LPD) providing 0.6 g protein/kg/day or a very-low-protein diet (VLPD) providing 0.3 g/kg/day supplemented with essential amino acids (EAA) or a mixture of essential amino acids and ketoacids (KA). Both diets reduce nitrogen intake while providing the physiological requirement of essential amino acids.
Many authors have demonstrated that VLPD þ KA has favorable effects on various metabolic consequences of uremia, including metabolic acidosis (Chauveau et al, 1999; Aparicio et al, 2000) , secondary hyperparathyroidism (Lindenau et al, 1990; Lafage et al, 1992; Barsotti et al, 1998) , peripheral resistance to insulin (Gin et al, 1987; Rigalleau et al, 1997) and hyperlipidemia (Ciardella et al, 1986; Bernard et al, 1996) . The correction of many such adverse effects of uremia by VLPD may be useful to delay the start of renal replacement therapy in patients with advanced CKD (Walser & Hill, 1999) .
Although concern has been raised about the nutritional adequacy of these diets and the risk for the subsequent development of malnutrition (Aparicio et al, 2001 ) studies have demonstrated that a VLPD þ KA in carefully selected and motivated patients with advanced CKD has no deleterious influence on some nutritional parameters in the predialysis phase of CKD (Mitch et al, 1982; Walser, 1993; Masud et al, 1994; Tom et al, 1995; Aparicio et al, 2001) . However, only a few studies have included a control group and patients that were previously following a conventional low protein diet.
The present study aimed to evaluate the effects on the nutritional and metabolic parameters of a VLPD supplemented with ketoacids in comparison with a conventional LPD in advanced CKD patients.
Subjects and methods

Patients
The study was performed with CKD patients treated at the outpatient clinic of Nephrology Division, Federal University of São Paulo-UNIFESP and Oswaldo Ramos Foundation. A total of 24 patients were selected after satisfying the following clinical inclusion criteria: creatinine clearance r25 ml/min/1.73 m 2 , older than 18 y, absence of catabolic illnesses, diabetes mellitus, auto-immune disease and malignant hypertension. The study was approved by the Human Investigation Review Committee of the Federal University of São Paulo-UNIFESP and informed consent was obtained from each patient.
Study protocol
A prospective, randomized, controlled clinical study was performed. After meeting the inclusion criteria and providing informed written consent, all patients were instructed to eat a low protein diet (0.6 g/kg ideal body weight/day) for a period of at least 1 month. After this period, the patients were randomly assigned to either a VLPD supplemented with a mixture of ketoacids and amino acids (VLPD þ KA group) or to keep the previous prescribed LPD (LPD group).
The patients were studied for a 4-month period. Once a month, the patients met with the dietitian and the physician for a complete clinical and biochemical evaluation and for encouragement and verification of compliance, safety and efficacy of the dietary prescription. At 2-monthly intervals, a complete nutritional assessment was performed.
The study protocol is depicted in Figure 1 .
Diet
The patients were carefully instructed by a skilled dietitian for the corresponding diet. The LPD diet consisted of 0.6 g/ kg/day of protein (50% of high biological value). Patients assigned to VLPD þ KA group were prescribed a 0.3 g/kg/day of vegetal origin protein diet supplemented with a mixture Very-low-protein diet in CKD SF Feiten et al of ketoacids and amino acids (Ketosteril s , Fresenius Kabi, Ltda, Bad Homburg, Germany). The ketoacid prescription consisted of one tablet/5 kg ideal body weight/day, divided into three doses taken during meals. The composition of the tablets is described in Table 1 . For both groups, energy prescription was 126-146 kJ/kg ideal body weight/day (30-35 kcal/kg ideal body weight/d). All patients were given supplements of vitamin B and iron and phosphate binders were prescribed when necessary.
Nutritional assessment Dietary assessment. Energy and nutrient intake were estimated from a 3-day food diary (3 week days), using a computer software developed at UNIFESP and the United States of America Department of Agriculture (1963) table as the nutrient data base. Protein intake was also estimated from the normalized protein equivalent of nitrogen appearance (nPNA), determined according to the formula of Sargent and Gotch (1979) using 24-h urinary urea excretion.
Anthropometric data and body composition. The following anthropometric parameters were evaluated: body weight, height, midarm circumference and triceps skinfold thickness (TSF). Body mass index (BMI) was calculated as body weight divided by squared height. The cutoff points used were as recommended by WHO-World Health Organization (1995) . Ideal body weight was obtained from the Metropolitan Life Insurance tables. The TSF was measured to the nearest millimeter using a Lange s skinfold caliper (Cambridge Instrument, Cambridge, MD, USA) and three sets of measurements were averaged. Midarm-muscle circumference (MAMC) was calculated from the measurement of midarm circumference and triceps skinfold thickness. The measurements were performed on the nondominant side of the body. Percent standard of TSF and MAMC were obtained using the National Health and Nutrition Examination Survey (NHANES) percentile distribution tables adapted by Frisancho (1981) .
Body composition was evaluated using bioelectrical impedance analysis (BIA) that was performed using a single frequency tetrapolar technique (800 A, 50 kHz, BIA 101 Quantum, RJL Systems, Detroit, MI, USA). The software Fluids & Nutrition (version 3.0) provided by the manufacturer was used to estimate the body composition.
Biochemical data. The patients had blood drawn under fasting conditions. The following biochemical data were measured on a monthly basis: serum and urinary urea and phosphorus, serum creatinine, ionized calcium, and bicarbonate. A 24-hour urine collection was obtained to measure protein excretion and to estimate glomerular filtration rate using standard creatinine clearance corrected for the body surface area (1.73 m 2 ). At 2-month intervals, two additional biochemical data were determined: albumin (bromocresol green technique, normal range 3.4-4.8 g/dl) and intact parathyroid hormone (immunofluorometric assay, normal values 10-70 pg/ml).
Statistical analysis
All data are expressed as mean7standard deviation (s.d.). The statistical analysis was performed considering three periods, baseline, 2 months and 4 months for anthropometric and dietary parameters and two periods, baseline and 4 months for biochemical parameters. Analysis of variance (ANOVA) complemented with Bonferroni test was employed for comparisons of anthropometric and dietary parameters from the three periods. Fisher's exact test was used for comparisons between groups, as applicable. Paired Student's t-test was used to compare the biochemical parameters between baseline and 4 months. The differences between the two periods comparing the two groups were analyzed using independent Student's t-test. Pearson's correlation coefficient was calculated to test quantitative associations between two variables. Statistical significance was defined as Po0.05. The software used for statistical analysis was True Epistat (Epistat Services, Richardson, TX, USA).
Results
Demographic and clinical characteristics of the patients at baseline are presented in Table 2 . There was a predominance of males in both groups and there was no difference in terms of age between them. Serum creatinine, urea nitrogen and urinary protein were similar in the two groups. According to the creatinine clearance the majority of patients (75%) were in stage 4 CKD. Hypertensive nephrosclerosis was the cause of CKD in seven patients in the VLPD þ KA group and in three patients in the LPD group while chronic glomerulonephritis was the cause of CKD in three patients only in the LPD group. Chronic interstitial nephritis was the etiology of CKD in one patient in the VLPD þ KA group and in two of them in the LPD group. Three patients and one patient of each group had undetermined and other causes of CKD, respectively. In total, 96% of the studied patients were taking furosemide as a diuretic. Antihypertensive medications were Analysis of follow-up Table 3 shows the anthropometric and dietary parameters of the two groups during the follow-up. At baseline, 50% of the patients in both groups presented a body mass index between 18.5 and 24.9 kg/m 2 and 50% of them were overweight (BMI 425 kg/m 2 ). As can be seen, BMI did not change in either group during the follow-up. Percent of body fat of the female and male patients at baseline was 34.079.6 and 17.673.1%, respectively, in the VLPD þ KA group, while in the LPD group it was 40.274.6 and 18.475.3%, respectively. In both groups, percent of body fat remained constant during the study. The mean standard percent of TSF and MAMC at baseline was within the normal range in both groups and did not change during the study in the VLPD þ KA group, while in the LPD group, the mean standard percent of TSF increased significantly but remained in the normal range. Lean body mass did not change during the follow-up in both groups.
Protein intake estimated by dietary diaries at baseline was according to the amount previously prescribed (0.6 g/kg/day) in both groups and as expected decreased significantly in the VLPD þ KA group during the follow-up. Protein intake estimated by PNA was approximately 28% higher than that calculated by dietary diaries in both groups at baseline. During the follow-up, PNA did not change in the LPD group and decreased significantly in the VLPD þ KA group. Energy intake was lower considering the recommendation and did not change in both groups throughout the entire observation period.
Phosphorus intake decreased significantly only in the VLPD þ KA group. Calcium intake was low and did not change during the 4-month study period in both groups. In the VLPD þ KA group, the calcium salts of the ketoacids lead to a significant increase in total calcium intake. Table 4 shows the biochemical parameters of the two groups at baseline and after 4 months. There was no change in creatinine clearance in both groups during the follow up, although a trend for a reduction was observed in the LPD group. Serum creatinine, albumin and bicarbonate were not modified in either group throughout the follow-up. Serum urea nitrogen decreased markedly in the VLPD þ KA group, but not significantly in the LPD group. In fact, serum urea nitrogen decreased in 11 patients (92%) in the VLPD þ KA group and in only six patients (50%) in the LPD group (Po0.07). Total serum cholesterol and serum glucose were within the normal range in both groups and did not change during the 4-month study period. Serum triglycerides was above the normal range in the LPD group and did not change during the follow-up. Although not significant, a tendency to increasing serum triglycerides was observed in the VLPD þ KA. Urinary phosphorus decreased significantly in the VLPD þ KA group and did not change in LPD group during the follow-up (Figure 2a) . Urinary phosphorus decreased in all patients in the VLPD þ KA group contrasting with only five (45%) in the LPD group (P ¼ 0.01). Serum calcium did not change during the entire observation period in both groups; however, in the LPD group a tendency for decreasing serum calcium was observed (Figure 2b ). Serum calcium increased in six patients (54%) in the VLPD þ KA group against only two patients (17%) in the LPD group (P ¼ 0.89). Serum phosphorus did not change in the LPD group but tended to decrease in the VLPD þ KA group (Figure 2c ). PTH concentration did not change during the 4-month study period in the VLPD þ KA group; however, it increased significantly in the LPD group (Figure 2d ). In fact, PTH concentration increased in 10 patients (83%) in the LPD group compared to only three patients (30%) in the VLPD þ KA group (Po0.03). Moreover, PTH concentration decreased in seven patients (70%) in the VLPD þ KA group and only in two patients (17%) in the LPD group (Po0.03).
Comparison between changes of the two groups during the follow-up As can be seen in Table 5 , significant differences in the changes from baseline to 4 months were observed when comparing VLPD þ KA and LPD group in the following parameters: protein intake, dietary phosphorus, dietary calcium, serum urea nitrogen, serum bicarbonate and urinary phosphorus. In the LPD group, the change in PTH concentration was negatively correlated with changes of ionized calcium concentration (r ¼ À0.75, P ¼ 0.02) and positively correlated with changes in serum phosphorus (r ¼ 0.71, P ¼ 0.03). Similar correlations were not observed in the VLPD þ KA group.
Discussion
In the present study, we demonstrated that a VLPD þ KA is safe to maintain the nutritional status of CKD patients at least during a 4-month period. In fact, the nutritional parameters, whether anthropometric or biochemical, were similarly preserved in both groups, even considering the important food restriction of a VLPD þ KA. Our results are in accordance with previous studies using VLPD þ KA for longer periods of time (Mitch et al, 1982; Walser, 1993; Masud et al, 1994; Tom et al, 1995) . Indeed, isotopic studies that evaluated protein metabolism showed that for both shortterm and long-term treatment periods, neutral or positive nitrogen balance is attained in patients receiving a VLPD þ KA, yet energy intake was below the recommended 146 kJ/kg/day (35 kcal/kg/day) (Masud et al, 1994; Tom et al, 1995) . Similar results regarding low energy intake and maintenance of nutritional parameters were also observed in the present study. Some possibilities can be raised to explain this apparent discrepancy. The first is that the energy requirements of these patients might be lower than the recommendation. In fact, Passey et al (2003) measuring the total energy expenditure and the dietary intake of predialysis patients following a conventional low protein diet found the majority of patients would meet their energy expenditure at 126 kJ/kg/day (30 kcal/kg/day) rather than the recommended 146 kJ/kg/day (35 kcal/kg/day). Moreover, some evidence for lower resting energy expenditure compared to healthy subjects has been recently demonstrated (O'Sullivan et al, 2002; Avesani et al, 2003) . Additionally, in our study the maintenance of the nutritional status even with low energy intake could be the result of a higher protein intake as demonstrated by PNA. Underestimation of energy intake is another possibility to explain the discrepancy observed in this study. In fact, studies using doubly labeled water to measure total energy expenditure in other populations have demonstrated approximately 20% underestimation in energy intake when food records were used (Martin et al, 1996; Kroke et al, 1999) . No study using this method of energy expenditure measurement has been performed in CKD patients. However, in a study comprising 24 CKD diabetic patients and 24 CKD nondiabetic patients, the resting energy expenditure (64387963 and 560571318 kJ/day (15387230 and 13397315 kcal/day), respectively) was very similar to the energy intake estimated by 4-day food records (608671515 and 611671754 kJ/day (14547362 and 14617419 kcal/day), respectively). As the body mass index was indicative of overweight (26.874.7 and 25.873.8 kg/m 2 , respectively), this result suggests some degree of underestimation of energy intake (Avesani et al, 2001) . Protein intake was indeed underestimated in the present study. In fact, we found that the protein intake estimated by food records was approximately 28% lower than that calculated by PNA in both groups during the entire study period. Taking into account the difference observed between these two methods, it is evident that the compliance of our patients was not good, even considering the significant decrease in protein intake in the VLPD þ KA group. It should be mentioned that our patients were in a clinically stable condition during the survey period, which excludes the possibility of the higher PNA being due to a catabolic state. Similar results were found by Bernhard et al (2001) who observed a protein intake estimated by food records 22% lower than that calculated by PNA. Other studies have also pointed out difficulties with compliance to very low protein diets even when individualized and intensive counseling are performed (Forget et al, 1990; Kopple et al, 1997) . Compliance is a complex and incompletely understood behavioral process that is strongly influenced by the environment in which people live and the social and cultural aspects of the individual life (Vitolino et al, 2000) . In the present study, although we have not evaluated the causes of the poor compliance of patients on the VLPD þ KA diet, it is likely that the difficulties were related to the restriction of animal protein origin, mainly meats, and to the increased intake of foods rich in vegetable proteins such as beans and bread as these foods are part of our population food habits. Additionally, the limitation of food choices could also have contributed.
One advantage of using VLPD þ KA is the reduction in serum urea nitrogen as demonstrated in many studies (Forget et al, 1990; Malvy et al, 1999; Aparicio et al, 2000) . In fact, a 28.9% of decrease in this biochemical marker was found in our study contrasting with only 7.9% in the LPD group. Although the present study did not aim to compare the differences in the glomerular filtration rate with both diets, a tendency was observed for decreasing creatinine clearance in the LPD group, but not in the VLPD þ KA group. Very-low-protein diet in CKD SF Feiten et al Similar results were found in the Modification of Diet in Renal Disease (MDRD) study B using a more adequate method to evaluate the glomerular filtration rate (clearance of I-iothalamate) (Klahr et al, 1994) . The elevated levels of triglycerides observed in the LPD group is a common finding in patients suffering from chronic renal failure. The tendency of increasing serum triglycerides observed in the VLPD þ KA group may be due to the increase in carbohydrate intake to counterbalance the reduction in protein intake.
The most significant finding from our study is related to the differences observed in calcium and phosphorus metabolism when comparing the two groups of diet. In contrast to the LPD group, in the VLPD þ KA group the significant reduction in phosphorus intake with a consequent decrease in urinary phosphorus may have contributed to the tendency of a reduction in serum phosphorus. Moreover, the calcium salts of the ketoacids may have acted as intestinal phosphate binder. Indeed, a previous study showed that ketoacids bind phosphorus in vitro as well in vivo (Schaefer et al, 1989) . Our result is in accordance with other studies that also found a reduction of serum phosphorus concentration in patients following a VLPD þ KA (Combe et al, 1995; Barsotti et al, 1998) . Serum calcium remained unchanged in both groups but a tendency to decrease was observed in the LPD group possibly as a consequence of a reduction in renal function evaluated by creatinine clearance and/or by the low calcium intake. On the other hand, in the VLPD þ KA group the calcium salt supplementation and the preservation of renal function may have contributed to the maintenance of serum calcium which, associated with a reduction in serum phosphorus, may have resulted in the maintenance of serum PTH, while the reduction of ionized calcium in the LPD group may have contributed to the increase in the concentration of PTH. In fact, the change in PTH concentration was negatively correlated with changes of ionized calcium concentration in this group. The benefits in calcium and phosphorus metabolism observed in the VLPD þ KA group may have implications in the treatment of hyperparathyroidism. Lindenau et al (1990) and Aparicio et al (1992) demonstrated that patients with advanced renal failure following a VLPD þ KA presented important improvement in bone histological changes related to hyperparathyroidism. It is already well demonstrated that a VLPD þ KA is effective in lowering serum PTH levels Combe et al, 1995; Barsotti et al, 1998) . Indeed, our results demonstrated a reduction in the PTH concentration among 70% of the patients following a VLPD þ KA.
In summary, this study indicates that a VLPD supplemented with ketoacids can maintain the nutritional status of the patients over a period of 4 months similarly to a conventional LPD. Moreover, an advantage in calcium and phosphorus metabolism and serum urea nitrogen reduction in the ketoacid group over LPD group was also demonstrated. Thus, VLPD þ KA can constitute another therapeutic alternative in the treatment of CKD patients. 
